RACGP warns undisclosed GLP-1 use raises perioperative aspiration risk
Australian GPs are told to ask directly about incretin drugs before surgery, as patients often omit them from medication lists.
MH
By Maren Holt · Senior Reporter, GLP-1
Oct 7 01:45 ETSource: Royal Australian College of General Practitioners (RACGP)
The wire
- 01The RACGP's newsGP reports a surgery safety warning that patients frequently do not disclose GLP-1 receptor agonist use, complicating anaesthetic planning around delayed gastric emptying.
- 02Clinicians and telehealth prescribers who initiate semaglutide or tirzepatide need to counsel patients to declare the drug before any procedure and document it clearly.
- 03The item is a professional body advisory rather than new outcome data; specific perioperative withholding periods remain contested across guidelines.
From the source
Read at www1.racgp.org.aunewsGP - Patients’ hidden GLP-1 use sparks surgery safety warning
